1. Home
  2. CRVS vs KSS Comparison

CRVS vs KSS Comparison

Compare CRVS & KSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$18.15

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Kohl's Corporation

KSS

Kohl's Corporation

HOLD

Current Price

$15.54

Market Cap

1.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRVS
KSS
Founded
2014
1962
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Department/Specialty Retail Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.4B
IPO Year
2016
1995

Fundamental Metrics

Financial Performance
Metric
CRVS
KSS
Price
$18.15
$15.54
Analyst Decision
Strong Buy
Sell
Analyst Count
6
15
Target Price
$30.17
$15.31
AVG Volume (30 Days)
966.0K
3.7M
Earning Date
05-07-2026
05-28-2026
Dividend Yield
N/A
3.15%
EPS Growth
48.04
142.86
EPS
N/A
2.38
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$0.21
P/E Ratio
N/A
$6.69
Revenue Growth
N/A
N/A
52 Week Low
$3.17
$6.47
52 Week High
$26.95
$25.22

Technical Indicators

Market Signals
Indicator
CRVS
KSS
Relative Strength Index (RSI) 64.18 63.14
Support Level $16.15 $15.10
Resistance Level $18.73 $16.95
Average True Range (ATR) 1.02 0.69
MACD 0.39 0.40
Stochastic Oscillator 70.07 84.07

Price Performance

Historical Comparison
CRVS
KSS

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

About KSS Kohl's Corporation

Kohl's is the second-largest traditional US department store company by sales. It has about 1,150 stores in 49 states and offers moderately priced private-label (31% of 2025 sales) and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most (about 80%) of its stores are in strip centers. Kohl's also has a large digital sales operation (29% of 2025 sales). Women's apparel is the retailer's largest category, having generated 24% of its 2025 sales. Kohl's is headquartered in Menomonee Falls, Wisconsin, and was founded in 1962.

Share on Social Networks: